Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fortress Biotech

1.89
-0.0600-3.08%
Post-market: 1.890.00000.00%16:04 EDT
Volume:191.69K
Turnover:369.53K
Market Cap:55.89M
PE:-0.86
High:2.00
Open:1.98
Low:1.88
Close:1.95
Loading ...

Fortress Biotech (FBIO) Receives a Buy from Roth MKM

TIPRANKS
·
17 Jul

Fortress Biotech Inc - AstraZeneca's Anselamimab Trial Did Not Achieve Statistical Significance - SEC Filing

THOMSON REUTERS
·
17 Jul

Mustang Bio Inc. Secures FDA Orphan Drug Designation for MB-101 to Treat Astrocytomas and Glioblastoma

Reuters
·
09 Jul

BUZZ-Mustang soars on FDA's orphan drug tag for brain cancer therapy

Reuters
·
08 Jul

BUZZ-U.S. STOCKS ON THE MOVE-U.S. Bancorp, IonQ, BlackRock

Reuters
·
08 Jul

Mustang Bio Granted Orphan Drug Designation by U.S. FDA for Mb-101 (Il13ra2-Targeted Car T-Cells) to Treat Astrocytomas and Glioblastoma

THOMSON REUTERS
·
07 Jul

Fortress Biotech Inc. Conducted Annual Stockholders Meeting

Reuters
·
23 Jun

Fortress Biotech’s Subsidiary Merges with Sun Pharma

TIPRANKS
·
06 Jun

Fortress Biotech Inc. Reports Significant Turnaround with Net Loss Converted to $14.999M Profit; EPS Jumps to $0.57

Reuters
·
06 Jun

Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics

THOMSON REUTERS
·
30 May

Press Release: Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics

Dow Jones
·
30 May

Checkpoint Therapeutics Inc. Announces April 2025 Agreement for Merger with Sun Pharmaceutical's Subsidiary

Reuters
·
30 May

Checkpoint Therapeutics Inc. Held Virtual Special Meeting on Merger Proposals

Reuters
·
29 May

Checkpoint Therapeutics Inc. Sets May 30, 2025, as Expected Closing Date for Merger with Sun Pharmaceutical Industries

Reuters
·
22 May

Avenue Therapeutics Inc. Reports Q1 Loss from Operations of $1.905M, Decrease from $3.708M in Prior Year

Reuters
·
21 May

Fortress Biotech Reports Q1 2025 Financial Highlights

TIPRANKS
·
20 May

Alliance Global Partners Sticks to Its Buy Rating for Fortress Biotech (FBIO)

TIPRANKS
·
20 May

Fortress Biotech Inc expected to post a loss of 49 cents a share - Earnings Preview

Reuters
·
17 May

Fortress Biotech Inc - Sun Pharma to Buy Checkpoint Therapeutics, Transaction to Take Place on May 28, 2025

THOMSON REUTERS
·
16 May

Fortress Biotech Inc - FDA Accepts Nda for Cutx-101 With Pdufa Date Sept 30, 2025

THOMSON REUTERS
·
16 May